Dr. Fawzi Damin Abukhalil, MD

Dr. Abukhalil practices at Broward Health Coral Springs in Coral Springs, Florida, part of North Broward Hospital District.

Dr. Abukhalil's NPI, 1881983773, was assigned on March 31, 2011. Dr. Abukhalil holds Florida license ME139191.

Dr. Abukhalil's primary practice is Broward Health Coral Springs, at 3000 Coral Hills Dr, Coral Springs, FL 33065 in Broward County. The practice phone is (954) 344-3121.

Dr. Abukhalil's primary practice is Broward Health Coral Springs in Coral Springs, Florida, part of North Broward Hospital District. Dr. Abukhalil is also affiliated with Broward Health Medical Center. The medical group on file is The Neurology Institute. Dmand AI also links Dr. Abukhalil to 3 more hospitals, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abukhalil practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Abukhalil's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Abukhalil is licensed in Florida.

CMS data shows 1,298 Medicare services from Dr. Abukhalil across 4 procedure codes in 2024, for 328 Medicare patients. Medicare paid $149,760 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 328 Medicare patients who saw Dr. Abukhalil in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abukhalil's median patient age at 73, with 54% women.

In 2022, Dr. Abukhalil wrote 47 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $1,331 in total drug cost. In 2021, CMS named 114 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Abukhalil for performance year 2024, reported individually. Dr. Abukhalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Abukhalil, published from 2012 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Retinal Ganglion Cells and Tomography, Optical Coherence. Dr. Abukhalil's most frequent co-authors are Byron L. Lam, MD, Aakash Nalinkant Bodhit, MD and Thomas M. Beaver, MD.

CMS Open Payments shows 25 general payments to Dr. Abukhalil from 11 drug and device companies from 2020 to 2022. Food and beverage make up the largest share, 94% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $141.